Free Access
Issue
Med Sci (Paris)
Volume 27, Number 1, Janvier 2011
Page(s) 107 - 109
Section Dernière heure
DOI https://doi.org/10.1051/medsci/2011271107
Published online 10 February 2011
  1. Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol 2010 ; 6 : 270-277. [CrossRef] [PubMed] [Google Scholar]
  2. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell 2007 ; 130 : 25-35. [CrossRef] [PubMed] [Google Scholar]
  3. Burnet FM. A reassessment of the forbidden clone hypothesis of autoimmune disease. Aust J Exp Biol Med Sci 1972 ; 50 : 1-9. [CrossRef] [PubMed] [Google Scholar]
  4. Magerus-Chatinet A, Neven B, Stolzenberg MC, et al. Onset of autoimmune lymphoproliferative syndrome ALPS in humans as a consequence of genetic defect accumulation. J Clin Invest 2010 ; 22 : décembre (online). [Google Scholar]
  5. Rieux-Laucat F. Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome. Curr Dir Autoimmun 2006 ; 9 : 18-36. [PubMed] [Google Scholar]
  6. Rieux-Laucat F. Autoimmune lymphoproliferative syndrome: an inherited or a somatic defect of apoptosis. Med Sci (Paris) 2006 ; 22 : 645-650. [PubMed] [Google Scholar]
  7. Teachey DT, Seif AE, Grupp SA Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Br J Haematol 2010 ; 148 : 205-216. [CrossRef] [PubMed] [Google Scholar]
  8. Bleesing JJ, Brown MR, Straus SE, et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 2001 ; 98 : 2466-2473. [CrossRef] [PubMed] [Google Scholar]
  9. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995 ; 268 : 1347-1349. [Google Scholar]
  10. Holzelova E, V.C., Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 2004 ; 351 : p. 1409-1418. [CrossRef] [PubMed] [Google Scholar]
  11. Magerus-Chatinet A, Stolzenberg MC, Loffredo MS, et al. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood 2009 ; 113 : 3027-3030. [CrossRef] [PubMed] [Google Scholar]
  12. Lopatin U, Yao X, Williams RK, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood 2001 ; 97 : 3161-3170. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.